Johnson & Johnson MedTech Slowed by Orthopedic Headwinds in 3Q24

Johnson & Johnson MedTech reported 3Q24 orthopedic sales of $2,189.8 million, up 1.2% compared to the third quarter of 2023. The company generated $6,842.2 million in orthopedic sales through the first nine months of 2024, up 2.5% compared to the year prior.

The company's orthopedic sales found modest success in joint replacement,...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0